Nagi Bioscience SA
PrivateLast Round
Series A
Sep 28, 2023
Total Funding Raised
$18.4M
Company Overview
Nagi Bioscience SA is a biotechnology company that develops and provides organism-on-chip technology for automated biological testing as an alternative to animal testing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Usage-Based SaaS, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nagi Bioscience SA Comparables
Compare Nagi Bioscience SA with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NemaLife | 82% | |
| ElegsLab | 80% | |
| Magnitude Biosciences | 78% |
Nagi Bioscience SA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 28, 2023 | ||||
| Grant | Mar 21, 2022 | ||||
| Seed | Dec 20, 2019 | ||||
| Accelerator | Jan 31, 2019 | ||||
| Grant | Jul 4, 2018 |
Nagi Bioscience SA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gebert Rüf Stiftung | Grant |
| Verve Ventures | Series A, Seed |
| imec.xpand | Series A |
| Swiss State Secretariat for Education, Research and Innovation (SERI) | Grant |
| Swisscanto Private Equity | Series A |
| Excellis Holding | Series A |
| Venture Kick | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 9, 2025
Rhino Bio Inc. will distribute analytical systems in South Korea.
- Sep 28, 2023
$14M round led by Swisscanto Private Equity and imec.xpand.
Nagi Bioscience SA Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nagi Bioscience SA's valuation, stock price, and market status.
Is Nagi Bioscience SA a public or private company?
Nagi Bioscience SA is a private company.
What is the current stock price of Nagi Bioscience SA?
Nagi Bioscience SA is a private company with no public stock price. No recent secondary market data is available.
How much is Nagi Bioscience SA worth (valuation)?
Valuation information for Nagi Bioscience SA is not publicly available.
Can I buy Nagi Bioscience SA stock?
Nagi Bioscience SA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Nagi Bioscience SA's last funding round?
Nagi Bioscience SA's most recent funding round was Series A on September 28, 2023.
Who are the main investors in Nagi Bioscience SA?
Key investors in Nagi Bioscience SA include Verve Ventures, imec.xpand.
Will Nagi Bioscience SA IPO soon?
No public IPO plans have been announced for Nagi Bioscience SA.
How can I track Nagi Bioscience SA secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nagi Bioscience SA's secondary market activity and sign up for updates.